Regulus Therapeutics Inc.
Regulus Therapeutics Inc. (RGLS) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 276 transactions totaling $150.4M, demonstrating a bearish sentiment with -$15.5M in net insider flow. The most recent transaction on Jul 25, 2024 involved a purchase of 4,000 shares valued at $7.3K.
RGLS Insider Activity Summary
Who Is Buying RGLS Stock?
No significant insider buying has been recorded for RGLS in the recent period.
Who Is Selling RGLS Stock?
No significant insider selling has been recorded for RGLS in the recent period.
Is Regulus Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RGLS is bearish with an Insider Alignment Score of 45/100 and a net flow of -$15.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RGLS Frequently Asked Questions
Understanding RGLS Insider Activity
Insider trading at Regulus Therapeutics Inc. (RGLS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading RGLS stock, having executed 276 transactions in the past 90 days. The most active insider is Ab Astrazeneca (Executive), who has made 1 transactions totaling $34.0M.
Related Tools
Track Regulus Therapeutics Inc. Insider Activity
Get notified when executives and directors at RGLS file new Form 4 transactions